Eularis staff routinely write columns and thought-leadership articles for other publications including EyeforPharma and PharmaPhorum.
Every year more companies enter the rare disease space due to heavy competition in the larger disease area and a faster path to market due to smaller trial sizes needed and greater precision medicine
Traditionally pharma sales reps selling to physicians was the largest slice of the sales and marketing pie but this has been shifting to a more integrated multi-channel approach. The challenge for
Artificial Intelligence is a valuable tool to aid pharma in both finding where their patients are (which physician) and aiding the physician in faster diagnosis if the condition is one that is more